Unitika (3103) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
19 Aug, 2025Executive summary
Net sales rose 8.1% year-over-year to ¥93,547 million for the nine months ended December 31, 2024, with operating profit at ¥4,294 million, reversing a prior-year loss.
Ordinary profit reached ¥5,007 million, aided by ¥1,241 million in foreign exchange gains, but a ¥31,621 million impairment loss led to a net loss attributable to owners of parent of ¥24,399 million.
Comprehensive income was negative ¥25,007 million, reflecting the large impairment and other comprehensive losses.
Financial highlights
Gross profit increased to ¥19,195 million from ¥13,360 million year-over-year.
Operating profit improved to ¥4,294 million from a loss of ¥2,618 million in the prior year.
Net assets fell to ¥13,240 million from ¥38,247 million at the previous fiscal year-end, mainly due to the impairment loss.
Total assets decreased to ¥157,204 million from ¥186,333 million, primarily from a decline in property, plant, and equipment.
Outlook and guidance
Full-year net sales forecast is ¥125,000 million (up 5.6% year-over-year), with operating and ordinary profit each at ¥5,000 million.
Net loss for the year is projected at ¥24,000 million, with EPS of ¥(416.27).
Forecasts were revised following recognition of extraordinary losses and business structure improvement expenses.
Latest events from Unitika
- Profit and margins surged on restructuring and asset sales, with a strong outlook for earnings.3103
Q3 20266 Feb 2026 - Operating profit surged on cost cuts and restructuring, but special losses led to a net loss.3103
Q2 202611 Nov 2025 - Operating profit returned to positive, but a major impairment loss drove a significant net loss.3103
Q2 202519 Aug 2025 - Strong profit recovery and higher sales, with Q2 outlook raised amid persistent cost risks.3103
Q1 202519 Aug 2025 - Operating profit rebounded, but restructuring costs drove a large net loss and no dividend was paid.3103
Q4 202519 Aug 2025